Tango Therapeutics (TNGX) Shares Issued: 2020-2024
Historic Shares Issued for Tango Therapeutics (TNGX) over the last 1 years, with Mar 2024 value amounting to $41.7 million.
- Tango Therapeutics' Shares Issued rose 57054.79% to $41.7 million in Q1 2024 from the same period last year, while for Mar 2024 it was $42.2 million, marking a year-over-year increase of 4702.05%. This contributed to the annual value of $689,000 for FY2023, which is N/A change from last year.
- As of Q1 2024, Tango Therapeutics' Shares Issued stood at $41.7 million, which was up 57,054.79% from $73,000 recorded in Q1 2023.
- Tango Therapeutics' Shares Issued's 5-year high stood at $166.8 million during Q3 2020, with a 5-year trough of $25,000 in Q2 2020.
- Over the past 3 years, Tango Therapeutics' median Shares Issued value was $265,000 (recorded in 2022), while the average stood at $14.0 million.
- In the last 5 years, Tango Therapeutics' Shares Issued plummeted by 99.94% in 2021 and then skyrocketed by 57,054.79% in 2024.
- Over the past 5 years, Tango Therapeutics' Shares Issued (Quarterly) stood at $166.8 million in 2020, then crashed by 99.94% to $101,000 in 2021, then plummeted by 39.64% to $265,000 in 2022, then slumped by 72.45% to $73,000 in 2023, then soared by 57,054.79% to $41.7 million in 2024.
- Its Shares Issued stands at $41.7 million for Q1 2024, versus $73,000 for Q1 2023 and $265,000 for Q1 2022.